Editing the RFX gene to reduce its protein expression is proposed to produce cells with altered immune recognition. Janssen Biotech’s patent application covers methods and materials for engineering such hypoimmunogenic cells. #JanssenBiotech #CellTherapy #US20260337579
November 2, 2026 at 6:09 AM
Editing the RFX gene to reduce its protein expression is proposed to produce cells with altered immune recognition. Janssen Biotech’s patent application covers methods and materials for engineering such hypoimmunogenic cells. #JanssenBiotech #CellTherapy #US20260337579